LOS ANGELES, Nov. 1 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. , a medical device and cell-based therapy company developing proprietary liver assist devices for the treatment of liver failure, today announced that Amy Factor, Chief Executive Officer of Arbios Systems, will be presenting at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on Monday, November 7, 2005 at 3:10 pm Eastern Time in New York City.
The presentation will be webcast live and can be accessed at http://www.wsw.com/webcast/rrshq7/abos/ or through the Company’s website at http://www.arbios.com. An archive of the presentation will be available for 90 days.
About Arbios
Arbios Systems, Inc. is a medical device and cell-based therapy company that is engaged in the discovery, acquisition and development of proprietary liver assist devices and new technologies useful in the diagnosis and treatment of liver failure. Arbios’ products in development include SEPET(TM), a novel blood purification therapy and HepatAssist-2(TM), a bioartificial liver combining liver cell therapy and sorbent-based detoxification. For further information on the Company, go to http://www.arbios.com.
Audio: http://www.wsw.com/webcast/rrshq7/abosArbios Systems, Inc.
CONTACT: Amy Factor, Chief Executive Officer, Arbios Systems, Inc.,+1-973-377-7665, amy@arbios.com; or Investors - Paula Schwartz,+1-917-322-2216, or Media - Pat Garrison, +1-917-322-2567, both of RXCommunications Group, for Arbios Systems, Inc.
Web site: http://www.arbios.com/
